February 16, 2009 - Registration is now open for the Heart Rhythm Society’s free Reality EP Webcast, “Role of 3D ICE and Epicardial Mapping in the Ablation of Ventricular Outflow Tract Tachycardia,” at 7 p.m. EDT Wednesday, March 4.
February 16, 2009 - Agfa HealthCare said today it completed the deployment of its IMPAX HeartStation ECG Management System at the National Heart Centre in Singapore.
February 16 - The CYPHER SELECT Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union (EU) for treatment of patients with diabetes, a complex and often difficult-to-treat patient population.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 13, 2009 - Roche Diagnostics has agreed to fund two new projects aimed at strengthening the commercial success of the Response Biomedical cardiovascular line of products, which Roche is expected to begin marketing in North America this quarter. Response Biomedical and Roche Diagnostics signed a strategic partnership in June 2008 to commercialize Response's cardiovascular tests.
February 13, 2009 – Toshiba America Medical Systems launched the Aquilion Premium CT system with the capability to cover up to 8 cm in a single rotation. The Aquilion Premium rounds out the company’s CT portfolio and is also field-upgradeable to an Aquilion ONE.
February 12, 2009 - Researchers in The Netherlands say the standard of care of using intra-aortic balloon pumps (IABP) in patients with high-risk STEMI does not appear to help patients, according to a meta-analysis conducted by the Department of Cardiology, Academic Medical Center, University of Amsterdam.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 12, 2009 - Endologix Inc. yesterday said a live-case demonstration of its new IntuiTrak Delivery System was featured at the International Congress XXII Endovascular Interventions conference in Scottsdale, AZ.
February 12, 2009 - Sanofi-aventis said yesterday the ATHENA trial was published in the New England Journal of Medicine, which shows its drug Multaq (dronedarone), in addition to standard therapy, significantly reduced the risk of first cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation (AF)/atrial flutter (AFL) or a recent history of these conditions.
February 12, 2009 - Osiris Therapeutics Inc. yesterday announced final two-year results for the company's trial evaluating Prochymal — a proprietary formulation of adult stem cells — for the treatment of acute myocardial infarction.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 12, 2009- Transoma Medical’s Sleuth AT (Advanced Trending) cardiac monitoring system, the company’s second-generation wireless, automated implanted cardiac monitoring (ICM) device, has received FDA clearance.
Vascular Solutions’ Minnie support catheter is designed to provide superior guidewire support and exchange for complex interventions, with versions designed for use with 0.014-inch, 0.018-inch and 0.035-inch guidewires.
Atherotech Inc. is a cardio-diagnostic laboratory focusing on cardiovascular tests to better assess both risk and management and prevention of cardiovascular disease. The company’s patented VAP technology directly measures all lipoproteins and their subclasses.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The AgileTrac system uses real time location system (RTLS) technology to track the locations of people and devices critical to advancing patient flow through the hospital. The system integrates key events and data from other clinical IT systems in the hospital in addition to its collection of real time data that is automatically fed into the system to manage patient workflow.
Itamar Medical said its Endo-PAT2000 is a simple, noninvasive, inexpensive, office-based diagnostic test for endothelial function, the earliest clinically detectable stage of cardiovascular disease.
The POWERHEART AED G3 Pro features semi-automatic operation, manual override option and three-lead ECG monitoring to give hospitals the tools they need to be in complete control. The color ECG displays the victim’s heart rate, waveform, number of shocks delivered and the elapsed rescue time – exactly what resuscitation teams need to know, the company said.